Back
Vincerx Pharma 10K Form
Sell
14
VINC
Vincerx Pharma
Last Price:
0.34
Seasonality Move:
3.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VINC News And Ratings
See the #1 stock for the next 7 days that we like better than VINC
VINC Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-5.83M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.52 |
| Price / Book: | 0.71 |
Profitability
| EPS (TTM): | -1.32000 |
|---|---|
| Net Income (TTM): | $-28.9M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Vincerx Pharma Earnings Forecast
Key Vincerx Pharma Financial Ratios
- The Interest Expense is -0.06% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 2 years.
Vincerx Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VINC |
| Website: | vincerx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VINC Technical Analysis vs Fundamental Analysis
Sell
14
Vincerx Pharma (VINC)
is a Sell
Is Vincerx Pharma a Buy or a Sell?
-
Vincerx Pharma stock is rated a Sell
The current Vincerx Pharma [VINC] share price is $0.35. The Score for VINC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.